Franceweylchem.com/companies/weylchem-lamotte-s-a-s
Its role Operator
WeylChem Lamotte SAS operates as a specialty chemicals manufacturer at its long-established industrial site in Trosly-Breuil, France. The company specializes in C2 organic chemistry, with core products including glyoxal and glyoxylic acid. It holds a leading global position in glyoxylic acid production and is the sole European manufacturer of this key intermediate used in pharmaceuticals such as amoxicillin and in flavor compounds like vanillin.
Additional activities encompass sulfuric acid and sulfur dioxide production, as well as custom fine chemical manufacturing and process development for clients in agrochemicals, pharmaceuticals, personal care, and polymer additives. The facility offers R&D scale-up capabilities, advanced oxidation and other technologies, and chemical warehousing services. Classified as a SEVESO high-threshold site, it maintains ISO 9001, 14001, and 50001 certifications along with Responsible Care commitments.
WeylChem Lamotte SAS belongs to the WeylChem Group of Companies, the fine chemicals platform of the privately held International Chemical Investors Group (ICIG). The site originated in 1896 under earlier entities and was restructured as the current SAS following ICIG acquisition in 2014. Employing approximately 400 staff, it qualifies as an Entreprise de Taille Intermédiaire (ETI) and has pursued recent investments in low-carbon production processes supported by French public funding.
Also known as WeylChem Lamotte S.A.S..
chemXplore tracks 1 project involving WeylChem Lamotte, of which one is active.
WeylChem is investing 15m euros to boost Glyoxal production in Lamotte, reducing the site's carbon footprint by 20%. The new plant will start in early 2024, supported by the French State and ADEME.
active all projects
What each is building and closing, and the pipelines and grids between them, on one map.
